Back to search
FDAFDA · Food and drugs·Recall number D-1080-2014

Dr. Reddy's Metoprolol Succinate Extended-Release Tablets USP, 50 mg 100 tablets Rx Only Mfd. By: Dr. Reddy's Laboratories Limited Bachepalli -500 090 INDIA NDC 55111-467-01

Published February 12, 2014 · Recall initiated: December 13, 2013

Summary

FDA records drug Class II recall D-1080-2014, published February 12, 2014 and initiated December 13, 2013. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 8,592 bottles; Lot: Lot # C207420 and C207416. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification; 12-Month stability interval.

What to do

Voluntary: Firm initiated · Letter

Get an email if METOPROLOL SUCCINATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METOPROLOL SUCCINATE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
LA, MI, MO, MS & OH
UPC
0355111466017
Lot
Lot # C207420 and C207416
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dr. Reddy's Metoprolol Succinate Extended-Release Tablets USP, 50 mg 100 tablets Rx Only Mfd. By: Dr. Reddy's Laboratories Limited Bachepalli -500 090 INDIA NDC 55111-467-01 recalled?

Yes. FDA published recall D-1080-2014 on February 12, 2014. Reported hazard: Failed Dissolution Specification; 12-Month stability interval.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METOPROLOL SUCCINATE. UPC: 0355111466017.